[Indications for coronary artery bypass grafting in the DES era]

Toshihiro Fukui1, Shuichiro Takanashi

  • 1Department of Cardiovascular Surgery, Sakakibara Heart Institute.

Insights

Coronary artery disease treatments like bypass grafting (CABG) and percutaneous coronary intervention (PCI) have advanced. CABG remains superior for complex cases, but treatment choice requires careful patient assessment.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Context:

  • Coronary artery disease (CAD) management involves surgical and interventional procedures.
  • Advancements in percutaneous coronary intervention (PCI) have altered patient referral patterns for coronary artery bypass grafting (CABG).
  • Patients now referred for CABG often present with more complex disease and significant comorbidities.

Purpose:

  • To analyze the evolving landscape of treatment selection for coronary artery disease.
  • To compare the efficacy of CABG versus PCI in contemporary patient populations.
  • To emphasize the importance of patient-specific factors in choosing between CABG, PCI, or hybrid approaches.

Summary:

  • While PCI has advanced, randomized trials indicate CABG offers superior outcomes regarding major adverse cardiac and cerebral events.
  • The patient population referred for CABG has shifted towards those with more severe and complex coronary artery disease.
  • Treatment decisions must integrate patient clinical status and coronary anatomy for optimal results.

Impact:

  • Highlights the continued importance of CABG for specific complex coronary artery disease scenarios.
  • Informs clinical decision-making for interventional cardiologists and cardiac surgeons.
  • Supports personalized treatment strategies in cardiovascular medicine, considering both procedural efficacy and patient complexity.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...